Sign in

You're signed outSign in or to get full access.

David Summers

About David Summers

Dr. David Summers (age 54) is an independent director of Destiny Media Technologies (DSNY) serving since February 28, 2019. He is a business development and technology commercialization consultant with prior leadership roles in industrial technology; the Board has determined he qualifies as an “audit committee financial expert” under Item 407(d)(5)(ii) of Regulation S‑K. He holds a BSc (Honours Chemistry) from Queen’s University, a Ph.D. in Chemistry from the University of British Columbia, and a dual MBA from Queen’s University and Cornell’s Johnson School; he is the author of 12 publications and 5 patents .

Past Roles

OrganizationRoleTenureCommittees/Impact
Chemetics Inc. (global engineering design for pulp & paper; mining & minerals)Director; responsible for technology development, electrolyzer business group, and global technical customer service2008–2016Led technology development and customer technical service globally
Carbon Credit Corp (private technology and consulting)Vice President, Business Operations2007–2008Positioned company for acquisition by Ledcor Group
Ballard Power SystemsProgressive leadership roles in R&D, Product Development, and Business Development1998–2007Senior leadership across R&D and commercialization; 12 publications, 5 patents

External Roles

OrganizationRoleTenureCommittees/Impact
Independent consultancy (business development & tech commercialization)ConsultantCurrentAdvisory/BD for commercialization initiatives
Public company directorshipsNoneN/ANone disclosed

Board Governance

  • Independence: Summers is independent under TSX Venture and Canadian NI 52‑110, and for purposes of Item 407(a) of Regulation S‑K using NYSE American standards .
  • Committees: Member of Audit, Compensation, and Nominating Committees; all members are independent under applicable standards .
  • Expertise: Designated by the Board as an “audit committee financial expert” (Item 407(d)(5)(ii) of Regulation S‑K) .
  • Attendance: FY2024—Board held 2 formal and 4 informal meetings; committees held 4 (Audit), 2 (Compensation), and 1 (Nominating); all members attended all meetings .
  • Board leadership: Independent Chair of the Board is Hyonmyong Cho; CEO/President is Frederick Vandenberg .
  • Audit Committee oversight: Related‑party transaction review, complaint procedures, pre‑approval of auditor services; committee relied on an exemption under Part 6.1 of NI 52‑110 .
  • Charters: Audit and Nominating Committee charters available on investors website; Compensation Committee charter available on company website .
  • Shareholder engagement signal: Only one director attended the 2024 annual meeting of stockholders (attendance otherwise recorded in minutes) .

Fixed Compensation

MetricFY 2024
Annual retainer (cash)$0
Committee membership fees$0
Committee chair fees$0
Meeting fees$0
Equity compensation (annual grant fair value)$0

Performance Compensation

Component / MetricFY 2024
Performance‑based cash bonus (director)Not applicable (no director compensation)
RSUs/PSUs (grant date, shares, fair value)Not applicable (no director compensation)
Options (strike, expiration, vesting)Not applicable (no director compensation)
Performance metrics tied to director pay (TSR, EBITDA, ESG)Not applicable (no director compensation)

The Company does not engage compensation consultants; neither the Compensation Committee nor management has engaged consultants to determine or recommend executive or director compensation .

Other Directorships & Interlocks

CompanyExchangeRoleCommittee RolesInterlock / Relationship
None disclosedNo other public company boards disclosed

Expertise & Qualifications

  • Designated audit committee financial expert; strengthens financial reporting oversight .
  • Deep industrial technology and commercialization background (Chemetics, Ballard, Carbon Credit Corp), with electrolyzer and R&D leadership experience .
  • Advanced degrees and cross‑border MBA credentialing (Queen’s/Cornell) .
  • Research and IP credentials (12 publications; 5 patents) .

Equity Ownership

As of DateShares Directly Owned (#)Options Exercisable within 60 days (#)Total Beneficial Ownership (#)Ownership % of Common Stock
Nov 30, 202423,381 93,334 116,715 1.2%

Outstanding common shares as of Nov 30, 2024: 9,639,420 (for ownership % context) .
No related‑party transactions disclosed since FY2022 commencement (reduces conflict risk) .

Insider Trades

PeriodReported Form 4 TransactionsProxy Disclosure Reference
FY 2024Not disclosed in proxy; Company states all Section 16(a) filing requirements were complied with during FY2024 Section 16(a) Beneficial Ownership Reporting Compliance

Governance Assessment

  • Positive signals: Independent status across jurisdictions; multi‑committee service; “audit committee financial expert” designation; full FY2024 attendance; no related‑party transactions—supports board effectiveness and investor confidence .
  • Compensation alignment: No director cash or equity compensation in FY2024—minimizes pay‑driven conflicts; but may challenge director recruitment/retention over time in competitive markets .
  • Process/oversight: Audit Committee charters and formal pre‑approval policies in place; robust scope including related‑party oversight .
  • Compensation governance: No external compensation consultants; executives may suggest compensation levels to the committee—a governance sensitivity that warrants monitoring .
  • Shareholder engagement: Only one director attended the 2024 annual meeting—could indicate limited direct shareholder interaction despite full meeting attendance elsewhere .
  • RED FLAGS: Board has not implemented a formal process for assessing its effectiveness; individual director/committee performance not formally assessed—structural governance weakness to address .
  • Structural context: Audit Committee relied on an exemption under NI 52‑110 Part 6.1—monitor rationale and implications for audit oversight rigor .